These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16568129)

  • 1. Immunosuppression for heart transplantation: where are we now?
    Kobashigawa JA; Patel JK
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.
    Zuckermann A; Manito N; Epailly E; Fiane A; Bara C; Delgado JF; Lehmkuhl H; Ross H; Eisen H; Chapman J; Valantine H
    J Heart Lung Transplant; 2008 Feb; 27(2):141-9. PubMed ID: 18267219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
    Jordan JL; Hirsch GM; Lee TD
    Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression.
    Söderlund C; Rådegran G
    Transplant Rev (Orlando); 2015 Jul; 29(3):181-9. PubMed ID: 25812489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-toxicity immunosuppressive therapy in renal transplant].
    Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
    Danger R; Giral M; Soulillou JP; Brouard S
    Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New advances in antirejection therapy.
    Chan M; Pearson GJ
    Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors.
    Eisen H; Kobashigawa J; Starling RC; Valantine H; Mancini D
    Transplant Proc; 2005 May; 37(4 Suppl):4S-17S. PubMed ID: 15809102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the early elimination of calcineurin inhibitors result in clinical benefits?
    Weir MR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S16-20. PubMed ID: 21095444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.